Is Moderna Inc halal to invest in?

As of July 2026, Moderna Inc MRNA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Moderna Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Moderna Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Moderna Inc?

Muslim investors may consider investing in Moderna Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Moderna Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Moderna Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Moderna Inc updated?

The Shariah compliance status of Moderna Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Moderna Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Moderna Inc?

You can check the latest Shariah compliance status of Moderna Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MRNA Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Moderna Inc is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

Moderna Inc. Stock Analysis MRNA

United States Health Care Large Cap Report: Q1, 2026

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The company is headquartered in Cambridge, Massachusetts and currently employs 4,700 full-time employees. The company went IPO on 2018-12-07. The company is engaged in developing medicines across infectious disease vaccines, oncology therapeutics and rare disease therapeutics. Its platform incorporates advances across three components, mRNA, delivery, and the manufacturing process, to advance its medicines. Its products are Spikevax and mNEXSPIKE (its COVID vaccines), and mRESVIA (its vaccine against respiratory syncytial virus (RSV)). The company also has a diverse development pipeline that consists of 35 therapeutic and vaccine programs, six of which are in late-stage development. The company has regulatory filings under review for its seasonal flu+COVID vaccine (mRNA-1083) in Europe and Canada and for its seasonal flu vaccine (mRNA-1010) in the United States, Europe, Canada and Australia. Its rare disease programs are Propionic acidemia (mRNA-3927); Methylmalonic acidemia (mRNA-3705), and Cystic Fibrosis (mRNA-3692/VX-522).

Key Statistics of Moderna Inc (MRNA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$54.39$57.07

Today's Open

$54.75

Volume

5.04M

P/E Ratio (TTM)

52 Week Range

$22.28$85.60

Market Cap

29.28B

Avg. Volume

7.56M

Dividend Yield

Financial Metrics & Statements of Moderna Inc (MRNA)

Super Investors Invested in Moderna Inc (MRNA)

FAQ's for Moderna Inc (MRNA)

As of July 2026, Moderna Inc MRNA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Moderna Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Moderna Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Moderna Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Moderna Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Moderna Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.